Indication
Atypical Parkinsonism
2 clinical trials
2 products
Clinical trial
A Phase 3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)Status: Recruiting, Estimated PCD: 2026-05-31
Product
AMX0035Clinical trial
TOPAZ: Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's DiseaseStatus: Recruiting, Estimated PCD: 2026-02-01
Product
Zoledronic Acid